Key Market Indicator:
F&G: 63
26.098,80 NASDAQ · 49.039,00 DOW · 6.980,55 S&P · 5.564,39 Gold · 67,99 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
© PR Newswire
28.01.2026
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba™ (Spinosad)
News Preview
MISSISSAUGA, ON, Jan. 28, 2026 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that Health Canada has accepted for review Cipher's new drug submission ("NDS") for Natroba™ (Spinosad), for the treatment of head lice and scabies. Natroba™ (Spinosad) is widely recognized as one of the most eff...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Reports Third Quarter 2025 Results
News Preview
(All figures are presented in U.S. Dollars) Adjusted EBITDA1 in Q3 2025 was $7.3 million, an increase of 79% over Q3 2024 NatrobaTM sales were $8.1 million during the quarter, a sequential increase...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call
News Preview
MISSISSAUGA, ON, Oct. 29, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the third quarter of 2025 after the market close on Thursday, November 6, 2025. The Company will also hold a conference call on Fr...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar

USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
14.10.2025
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Receives Successful Arbitration Award
News Preview
MISSISSAUGA, ON, Oct. 14, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") has received a favourable award from an extensive and comprehensive arbitration proceeding, related to a contractual dispute with Sun Pharmaceuticals Industries, Inc. ("Sun") regarding Sun's br...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© PR Newswire
26.08.2025
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Announces the Passing of Director Mr. Harold Wolkin
News Preview
MISSISSAUGA, ON, Aug. 26, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announces with great sadness the passing of Harold M. Wolkin, a valued member of the Company's Board of Directors (the "Board") and Chairman of the Audit Committee.  Mr. Wolkin was a very active member of the Board and his dee...
Themefolio
Profiler
Peergroup
© PR Newswire
07.08.2025
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue
News Preview
(All figures are presented in U.S. Dollars) Highest single-quarter revenue in the Company's history with total revenue of $13.4 million in Q2 2025Adjusted EBITDA1 in Q2 2025 was $7.6 million, an increase of 148% over Q2 2024Epuris sales volumes grew 14% in the quarter compared to Q2 2024NatrobaTM sales were $7.8 million during the quarter, a sequ...
Themefolio
Profiler
Peergroup
© PR Newswire
29.07.2025
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call
News Preview
MISSISSAUGA, ON, July 29, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the second quarter of 2025 after the market close on Thursday, August 7, 2025. The Company will also hold a conference call on Friday, August 8, 2025 at 8:30am ET t...
Themefolio
Profiler
Peergroup
© PR Newswire
13.06.2025
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders
News Preview
MISSISSAUGA, ON, June 13, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announced that it held its annual and special meeting of shareholders earlier today and that all matters put forward before shareholders for consideration and approval as set out in the Company's management information circular...
Themefolio
Profiler
Peergroup
© PR Newswire
08.05.2025
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Reports First Quarter 2025 Results, and Announces $15 Million Debt Repayment
News Preview
(All figures are presented in U.S. Dollars) Adjusted EBITDA2 in Q1 2025 was $6.2 million, an increase of 73% over Q1 2024Canadian product portfolio sales volumes grew 46% in the quarter compared to Q1 2024NatrobaTM sales were $6.7 million during the quarter, a sequential increase of 3% over Q4 2024Continued strong track record of cash generation...
Themefolio
Profiler
Peergroup
© PR Newswire
02.05.2025
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Schedules Q1 2025 Earnings Release and Conference Call
News Preview
MISSISSAUGA, ON, May 2, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the first quarter of 2025 after the market close on Thursday, May 8, 2025. The Company will also hold a conference call on Friday, May 9, 2025 at 8:30am ET to discuss...
Themefolio
Profiler
Peergroup
© PR Newswire
01.05.2025
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Announces Normal Course Issuer Bid, Including Intention to Utilize Block Purchases
News Preview
MISSISSAUGA, ON, May 1, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or "the Company") announced today that it has filed, and the Toronto Stock Exchange (the "TSX") has accepted, notice of Cipher's intention to commence a normal course issuer bid ("NCIB") for its common shares (the "Common Shares"). The TSX notice...
Themefolio
Profiler
Peergroup
© PR Newswire
29.04.2025
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Secures Medicaid Step-Through Preferred Status for Natroba™ in the state of Illinois
News Preview
MISSISSAUGA, ON, April 29, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") proudly announces the state of Illinois has updated its Preferred Drug Listing ("PDL") where Cipher's product Natroba™, for the treatment of scabies and head lice, has obtained preferred drug status on Medicaid state plans, an...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
18.03.2025
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results
News Preview
(All figures are presented in U.S. Dollars) Generated $8.3 million in cash during Q4 2024Natroba™ revenue was $12.0 million for the 5 months of fiscal 2024 since acquisitionFull year adjusted EBITDA1 of $15.7 million, an increase of 23% over fiscal 2023Cash at December 31, 2024 was $17.8 million or $0.70 per outstanding common shareEpuris revenue...
Themefolio
Profiler
Peergroup
© PR Newswire
11.03.2025
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Schedules Q4 & Fiscal 2024 Earnings Release and Conference Call
News Preview
MISSISSAUGA, ON, March 11, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the fourth quarter and fiscal 2024 after the market close on Tuesday, March 18, 2025. The Company will also hold a conference call on Wednesday, March 19, 2025 at...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2024
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Partner Moberg Pharma AB Reports Topline Data in MOB-015 Phase 3 Study
News Preview
MISSISSAUGA, ON, Dec. 10, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announced today that its partner, Moberg Pharma AB ("Moberg"), issued a news release earlier today stating that MOB-015, a product for the treatment of nail fungus, did not meet the primary endpoint in the North American Phase...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2024
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Reports Third Quarter 2024 Results
News Preview
(All figures are presented in U.S. Dollars) Successfully closed the acquisition of the U.S. based Natroba™ business on July 26, 2024Epuris sales volumes grew 29% compared to Q3 2023, continuing growth trajectory for the fifth consecutive quarterStrong product gross margin from the acquired Natroba products of 85%Added management depth with appoin...
Themefolio
Profiler
Peergroup
© PR Newswire
04.11.2024
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Schedules Q3 2024 Earnings Release and Conference Call
News Preview
MISSISSAUGA, ON, Nov. 4, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the third quarter of 2024 after the market close on Thursday, November 7, 2024. The Company will also hold a conference call on Friday, November 8, 2024 at 8:30am ET...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2024
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Enhances Leadership Team with Appointment of New Chief Business Officer
News Preview
MISSISSAUGA, ON, Oct. 8, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announced today the appointment of Hamed Ghanei as Chief Business Officer ("CBO"). Craig Mull, Interim Chief Executive Officer, commented on the appointment: "I am delighted to announce the addition of Dr. Ghanei to Cipher's ex...
Themefolio
Profiler
Peergroup
© PR Newswire
13.09.2024
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Partner Moberg Pharma AB Provides Update on MOB-015 Phase 3 Study
News Preview
MISSISSAUGA, ON, Sept. 13, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announced today that its partner, Moberg Pharma AB ("Moberg"), issued a news release earlier today stating that it has received information about clinical cure in a subset of patients in the ongoing North American Phase 3 stud...
Themefolio
Profiler
Peergroup
© PR Newswire
13.09.2024
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Canadian Investment Regulatory Organization Trade Resumption - CPH
News Preview
TORONTO, Sept. 13, 2024 /CNW/ - Trading resumes in: Company: Cipher Pharmaceuticals Inc. TSX Symbol: CPH All Issues: No Resumption (ET): 10:12:56 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the...
Themefolio
Profiler
Peergroup
© PR Newswire
13.09.2024
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Canadian Investment Regulatory Organization Trading Halt - CPH
News Preview
TORONTO, Sept. 13, 2024 /CNW/ - The following issues have been halted by CIRO: Company: Cipher Pharmaceuticals Inc. TSX Symbol: CPH All Issues: No Reason: Single Stock Circuit Breaker Halt Time (ET): 10:07:56 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts a...
Themefolio
Profiler
Peergroup
© PR Newswire
08.08.2024
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Reports Second Quarter 2024 Results
News Preview
(All figures are presented in U.S. Dollars) Adjusted EBITDA was $3.1 million in Q2 2024, consistent with Q2 2023Epuris sales volumes grew 13% compared to Q2 2023, continuing its growth trajectory for the fourth consecutive quarterStrong operating cash flows of $6.2 million in Q2 2024Management changes to take effect on August 10, 2024:CFO Bryan J...
Themefolio
Profiler
Peergroup
© Newsfile
03.04.2024
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
News Preview
Mississauga, Ontario--(Newsfile Corp. - April 3, 2024) - Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre. Dates:Tuesday April 16, 2024-Wednesday April 17, 2024Time:8:30 AM-5:00...
Themefolio
Profiler
Peergroup
© Newsfile
18.04.2023
ISIN: CA17253X1050

Cipher Pharmaceuticals Inc.
CPH

LISTED

TSX
Cipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
News Preview
Mississauga, Ontario--(Newsfile Corp. - April 18, 2023) - Cipher Pharmaceuticals (TSX: CPH), a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro To...
Themefolio
Profiler
Peergroup

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2026 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2026 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Thursday, 29.01.2026, Calendar Week 05, 29th day of the year, 336 days remaining until EoY.